353530 <common-name>1-n-butyl-4-[3-[2-[1-[1-(butylcarbamoyl)-4-carbamoylpiperidin-4-yl]piperidin-3-yl]ethyl]piperidin-1-yl]piperidine-1,4-dicarboxamide</common-name> <description>1-n-butyl-4-[3-[2-[1-[1-(butylcarbamoyl)-4-carbamoylpiperidin-4-yl]piperidin-3-yl]ethyl]piperidin-1-yl]piperidine-1,4-dicarboxamide is a chemical compound with the formula C34H62N8O4. With an average molecular weight of 646.90 g/mol, 1-n-butyl-4-[3-[2-[1-[1-(butylcarbamoyl)-4-carbamoylpiperidin-4-yl]piperidin-3-yl]ethyl]piperidin-1-yl]piperidine-1,4-dicarboxamide is a heavy molecule.</description> <cas>40958-73-4</cas> <pubchem-id>218625</pubchem-id> <chemical-formula>C34H62N8O4</chemical-formula> <weight>646.9</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T20:30:14Z</created-at> <updated-at type="dateTime">2026-08-31T20:30:14Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCCCNC(=O)N1CCC(CC1)(C(=O)N)N2CCCC(C2)CCC3CCCN(C3)C4(CCN(CC4)C(=O)NCCCC)C(=O)N</moldb-smiles> <moldb-formula>C34H62N8O4</moldb-formula> <moldb-inchi>InChI=1S/C34H62N8O4/c1-3-5-17-37-31(45)39-21-13-33(14-22-39,29(35)43)41-19-7-9-27(25-41)11-12-28-10-8-20-42(26-28)34(30(36)44)15-23-40(24-16-34)32(46)38-18-6-4-2/h27-28H,3-26H2,1-2H3,(H2,35,43)(H2,36,44)(H,37,45)(H,38,46)</moldb-inchi> <moldb-inchikey>UDENZTJTQMYUBE-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">646.4894025</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>2.2</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM349423</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>1-n-butyl-4-[3-[2-[1-[1-(butylcarbamoyl)-4-carbamoylpiperidin-4-yl]piperidin-3-yl]ethyl]piperidin-1-yl]piperidine-1,4-dicarboxamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0303812</sync-id> <structure-inchikey>UDENZTJTQMYUBE-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000100000000800000000000000800000000000004000020000000000400000002000000000000000000000000000000000000020000000008000000000100000000000000010000000000000020001000000000000000001001000008002020010000008000000000000001000000020100008000000000000000100800000048000000000000004000000080201000000000000001000000000000000000000004000000000400000000000080000000000008008000000000000000000000000000000000000000000000000000020000000000000000000000000000000000000000000009000000010400000000000080000000004000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAuAAAAMQAAAIABBgBgAAAAAQMGAGAAAAAC AgYAYAAAAAICBgBgAAAAAgIHAGgAAAADAgEGACgAAAADBAgAKAAAAAMCBwAo AAAAAwMGAGAAAAACAgYAYAAAAAICBgAgAAAABAYAYAAAAAICBgBgAAAAAgIG ACgAAAADBAgAKAAAAAMCBwBoAAAAAwECBwAgAAAAAwYAYAAAAAICBgBgAAAA AgIGAGAAAAACAgYAYAAAAAMBBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBg AAAAAwEGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIHACAAAAADBgBgAAAAAgIG ACAAAAAEBgBgAAAAAgIGAGAAAAACAgcAKAAAAAMDBgBgAAAAAgIGAGAAAAAC AgYAKAAAAAMECAAoAAAAAwIHAGgAAAADAgEGAGAAAAACAgYAYAAAAAICBgBg AAAAAgIGAGAAAAABAwYAKAAAAAMECAAoAAAAAwIHAGgAAAADAQILAAEAAQIA AgMAAwQABAUgBQYoAgUHIAcIAAgJAAkKAAoLAAsMAAoNAA0OKAINDyAKEAAQ EQAREgASEwATFAAUFQAUFgAWFwAXGAAYGQAZGgAaGwAbHAAcHQAcHgAeHwAf IAAgIQAhIgAiIwAhJCAkJSgCJCYgJicAJygAKCkAKSoAHisAKywoAistIAwH ABUQAB0YACMeAEIEAAAABgcMCwoJCAYREhMUFRAGGRobHB0YBh8gISIjHhcE AAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:51:18Z</structure-indexed-at> </compound>